News for Ocugen, Inc. (OCGN)

PHILADELPHIA, March 03, 2025 (GLOBE NEWSWIRE) —

Atkore Inc. (NYSE: ATKR):

**media[546596]**

Ocugen (OCGN) said it has received a positive opinion from EU regulators for Advanced Therapy Medicinal Product classification for its gene therapy OCU400. Read more here.

OCU500 will be administered via inhalation and as a nasal sprayCOVID-19 remains a substantial public health threat in the U.S. and around the worldPhase 1 clini

MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (”œOcugen” or the ”œCompany”) ( OCGN), a biotechnology company focused on discovering, deve

100% (9/9) of treated evaluable subjects demonstrated improvement or preservation in visual function compared to untreated eyes at both one and two years100% (9

**media[513301]**

MALVERN, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) ( OCGN), a biotechnology company focused on discovering, developing, and

MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) ( OCGN), a biotechnology company focused on discovering, developing, and

Ocugen (OCGN) reported positive Phase 1 data for its gene therapy candidate OCU410 in the treatment of geographic atrophy. Read more here.

Ocugen (OCGN) delivered earnings and revenue surprises of 0% and 5.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Cash and Restricted Cash: $39 million as of September 30, 2024, compared to $39.5 million as of December 31, 2023.Total Operating Expenses: $14.4 million for t

Nov 08, 2024 / 01:30PM GMTOperator Good morning and welcome to Ocugen's third quarter, 2024 financial results and business update. Please note that this call is

Ocugen, Inc. (NASDAQ:OCGN) Q3 2024 Earnings Conference Call November 11, 2024 8:30 AM ETCompany ParticipantsTiffany Hamilton - Head of Corporate...

**media[460166]**

The gene therapies market is experiencing significant growth, driven by advancements in research and technology. According to DelveInsight, the gene...

Oklo, NuScale surge as Google backs new small nuclear reactors to power AI. Frontier's second-largest holder plans to vote against sale to Verizon - Reuters.

UAE-based Lytus Technologies Holdings PTV. Ltd. (LYT) is up over 109 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.